CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 Revenues: Clearing and transaction fees 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 Market data and information services 139.4 139.8 144.2 145.2 145.4 142.1 151.7 151.7 154.3 Other Revenue 105.9 115.7 102.1 104.1 85.6 55.9 56.8 60.9 74.9 Total revenues 1,080.7 1,098.5 1,253.3 1,179.2 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 Expenses: Compensation and benefits 216.4 215.6 225.0 211.7 198.6 201.7 185.2 185.3 189.6 Technology 48.1 53.6 48.2 49.3 49.3 45.8 45.9 45.9 46.8 Professional fees and outside services 48.4 50.0 37.4 36.8 45.2 32.3 31.8 32.0 35.1 Amortization of purchased intangibles 78.3 79.0 60.6 59.4 59.0 58.6 58.4 57.1 55.5 Depreciation and amortization 39.7 41.5 37.6 37.1 37.2 35.9 33.5 33.0 34.5 Licensing and other fee agreements 57.7 57.9 64.7 54.2 57.6 60.4 80.9 83.1 83.6 Other expense 67.1 85.9 54.7 56.0 49.3 80.9 51.8 51.1 43.9 Operating expenses 555.7 583.5 528.2 504.5 496.2 515.6 487.5 487.5 489.0 Operating Income 525.0 515.0 725.1 674.7 613.7 631.7 859.1 749.7 738.8 Operating Margin 49% 47% 58% 57% 55% 55% 64% 61% 60% Non-operating Income and Expense Investment income 23.6 31.1 30.9 62.4 145.8 67.8 73.1 286.9 686.2 Interest and other borrowing costs (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) Equity in net gains (losses) of unconsolidated subsidiaries 44.0 46.6 56.2 55.7 66.4 67.5 73.3 87.3 76.5 Other non-operating income (expense) (14.4) (16.0) (18.4) (25.0) 311.8 74.2 (46.7) (217.3) (581.1) Non-operating income (expense) 11.5 20.0 27.2 51.4 482.2 167.6 57.2 117.0 141.2 Income before income taxes 536.5 535.0 752.3 726.1 1,095.9 799.3 916.3 866.7 880.0 Income taxes 125.0 110.2 177.5 215.5 169.6 174.1 205.3 204.2 200.4 Net income 411.5 424.8 574.8 510.6 926.3 625.2 711.0 662.5 679.6 Less: net income (loss) attributable to NCI (0.2) 0.8 0.4 0.3 (0.2) - - - Net Income Attributable to CME Group 411.7 424.0 574.4 510.3 926.5 625.2 711.0 662.5 679.6 Net Income Attributable to CME Group 411.7 424.0 574.4 510.3 926.5 613.3 702.0 654.1 671.1 Effective Tax Rate 23.3% 20.6% 23.6% 29.7% 15.5% 21.8% 22.4% 23.6% 22.8% Earnings per Share: Basic EPS 1.15 1.18 1.60 1.42 2.59 1.71 1.96 1.82 1.87 Diluted EPS 1.15 1.18 1.60 1.42 2.58 1.71 1.95 1.82 1.87 Weighted average number of common stock shares: Basic Shares 357,791 358,047 358,147 358,261 358,363 358,582 358,609 358,641 358,715 Diluted Shares 358,590 358,612 358,817 358,888 358,988 359,019 359,180 359,205 359,288 Preferred Shares 2,890 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q320 Q420 Q121 Q221 Q321 Q421 Q122 Q222 Q322 Revenues: Clearing and transaction fees 835.4 843.0 1,007.0 929.9 878.9 949.3 1,138.1 1,024.6 998.6 Market data and information services 139.4 139.8 144.2 145.2 145.4 142.1 151.7 151.7 154.3 Other Revenue 105.9 115.7 102.1 101.0 85.6 55.9 56.8 60.9 74.9 Total revenues 1,080.7 1,098.5 1,253.3 1,176.1 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 Expenses: Compensation and benefits 205.5 202.6 207.5 201.9 191.1 183.7 182.8 189.5 189.1 Technology 47.3 52.2 47.7 49.2 49.1 45.6 45.8 45.9 46.8 Professional fees and outside services 40.0 39.2 27.9 30.0 26.5 27.2 30.3 31.4 35.1 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 37.0 37.2 36.8 36.7 36.7 35.6 33.5 32.9 33.8 Licensing and other fee agreements 57.7 57.9 64.7 54.2 57.6 60.4 80.9 83.1 81.9 Other expense 56.1 74.3 52.1 54.8 51.3 76.5 51.7 59.6 54.4 Operating expenses 443.6 463.4 436.7 426.8 412.3 429.0 425.0 442.4 441.1 Operating Income 637.1 635.1 816.6 749.3 697.6 718.3 921.6 794.8 786.7 Operating Margin 59% 58% 65% 64% 63% 63% 68% 64% 64% Non-operating Income and Expense Investment income 22.6 24.1 26.9 37.3 55.1 58.2 74.7 299.5 688.5 Interest and other borrowing costs (41.7) (41.7) (41.5) (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) Equity in net gains (losses) of unconsolidated subsidiaries 44.0 46.6 56.2 55.7 70.5 78.7 84.7 98.2 89.6 Other non-operating income (expense) (14.4) (16.0) (18.4) (25.0) (32.9) (33.0) (43.4) (218.5) (585.7) Non-operating income (expense) 10.5 13.0 23.2 26.3 50.9 62.0 73.5 139.3 152.0 Income before income taxes 647.6 648.1 839.8 775.6 748.5 780.3 995.1 934.1 938.7 Income taxes 152.8 150.2 198.2 186.7 174.3 172.8 228.9 217.6 219.6 Net income 494.8 497.9 641.6 588.9 574.2 607.5 766.2 716.5 719.1 Less: net income (loss) attributable to NCI (0.2) 0.8 0.4 0.3 (0.2) - - - Net Income Attributable to CME Group 495.0 497.1 641.2 588.6 574.4 607.5 766.2 716.5 719.1 Net Income Attributable to Common Shareholders of CME Group 495.0 497.1 641.2 588.6 574.4 595.7 756.6 707.5 710.0 Effective Tax Rate 23.6% 23.2% 23.6% 24.1% 23.3% 22.1% 23.0% 23.3% 23.4% Earnings per Share: Basic EPS 1.38 1.39 1.79 1.64 1.60 1.66 2.11 1.97 1.98 Diluted EPS 1.38 1.39 1.79 1.64 1.60 1.66 2.11 1.97 1.98 Weighted average number of common stock shares: Basic Shares 357,791 358,047 358,147 358,261 358,363 358,582 358,609 358,641 358,715 Diluted Shares 358,590 358,612 358,817 358,888 358,988 359,019 359,180 359,205 359,288 Preferred Shares - - - - - 2,890 4,584 4,584 4,584 -- 2 of 2 --